Why journal editors should dig deeper when authors ask for a retraction

Imagine you’re a journal editor. A group of authors sends you a request to retract one of their papers, saying that “during figure assembly certain images were inappropriately processed.”

What do you do next? Do you ask some tough questions about just what “inappropriately processed” means? Do you check your files for whether the author’s institution had told you about an investigation into the work? Do you Google the author’s names? Do you…search Retraction Watch?

It seems unlikely that any of those things happened in the case of a recent retraction from Nature Communications, or, if they did, they don’t seem to have informed the notice. We don’t know for sure, because, as is typical, the journal isn’t saying much. But here’s what we do know. Continue reading Why journal editors should dig deeper when authors ask for a retraction

Journal retracts more than 400 papers at once

Ladies and gentlemen, we appear to have a new record.

The Journal of Fundamental and Applied Sciences (JFAS) recently retracted 434 articles from three issues of their journal. Yes, 434, giving it more retractions than any other journal ever, according to our records.

All of the articles, on topics ranging from “Effect of olive leaf extract on calcaeous deposit from sea” to “Optimization of mobile user data sharing on secure cloud,” have now been replaced with this notice: Continue reading Journal retracts more than 400 papers at once

Controversial pediatrics researcher has 20-year-old paper retracted for misconduct

A journal has retracted a paper on a drug for a blood disorder 20 years after it was published — and 17 years after an author of the article was told to request the move by his university.

The retraction is of a paper in Therapeutic Drug Monitoring by Gideon Koren and colleagues, then at the University of Toronto (U of T): Continue reading Controversial pediatrics researcher has 20-year-old paper retracted for misconduct

Found in translation: Authors blame language barriers after forging co-authors

When the merde hits the fan, blame the translator. That’s Rule 1 of botched international diplomacy — and, evidently, botched international science.

Otolaryngology researchers in China have lost their 2018 paper in the American Journal of Translational Research for what they’re calling (with some degree of chutzpah) language barriers.

The article, “Therapeutic ultrasound potentiates the anti-nociceptive and anti-inflammatory effects of curcumin to postoperative pain via Sirt1/NF-κB signaling pathway,” came from group whose primary affiliation was the Second Military Medical University in Shanghai. (It hasn’t been cited, according to Clarivate’s Web of Science.) However, the list of authors also included several scientists in Germany.

Evidently, the Germans were most unzufrieden.

According to the retraction notice: Continue reading Found in translation: Authors blame language barriers after forging co-authors

Weekend reads: Article retracted because of “racial characterizations;” India’s high retraction rate; meet the fraud finder

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured a judge’s ruling that a university could not revoke a PhD; an author who stole a manuscript during peer review; and corrections because a researcher threatened to sue for using his scale. Here’s what was happening elsewhere: Continue reading Weekend reads: Article retracted because of “racial characterizations;” India’s high retraction rate; meet the fraud finder

Legal threats once again force corrections over a scale measuring medication usage

Donald Morisky

A journal is warning contributors that they should avoid using a controversial scale for assessing adherence to medication regimens or they might wind up wearing an omelette on their faces.

The chicken here, of course, is the Morisky Medication Adherence Scale. The instrument was developed by a UCLA professor named Donald Morisky, who with a colleague named Steve Trubow threatens to sue anyone who they believe misuses the tool after failing to obtain a license.

As we have detailed on this blog and in Science, many researchers report that Morisky and Trubow seem to set traps for them, ignoring their requests for a license then hammering them with demands for citations, money — often tens of thousands of dollars or more — or both once their work has been published. Failure to comply, the pair assert, could lead to a lawsuit. (Morisky sometimes fails to note his own financial conflict here, as he did in this 2017 paper in PLOS One touting the accuracy of his tool.) Continue reading Legal threats once again force corrections over a scale measuring medication usage

A reviewer stole a manuscript and published it himself. But you wouldn’t know it from this retraction notice.

The Taylor & Francis logo

Fish off someone else’s peer review!

So writes (in somewhat different words) Mina Mehregan, a mechanical engineer at Ferdowsi University of Mashhad in Iran. Mehregan and a colleague recently discovered that they’d been victimized by a group of unscrupulous reviewers who used the pretext of a long turnaround time to publish a hijacked version of their manuscript in another journal.

In a guest editorial for the Journal of Korean Medical Science — which wasn’t involved in the heist — Mehregan began by noting the toll that protracted peer review can take on authors: Continue reading A reviewer stole a manuscript and published it himself. But you wouldn’t know it from this retraction notice.

Do the humanities need a replication drive? A debate rages on

Rik Peels

Since last year, a half-dozen researchers have been having a debate: Should the humanities focus on replication? No, said Sarah de Rijcke and Bart Penders in Nature last August: “Resist calls for replicability in the humanities.” In the most recent piece on this subject, de Rijcke and Penders were joined by J. Britt Holbrook to again say “no.” Here, Rik Peels, Lex Bouter, and René van Woudenberg, who have been in the “yes” camp, respond. Continue reading Do the humanities need a replication drive? A debate rages on

University of Texas lacks authority to revoke PhDs, judge rules

The University of Texas (UT) at Austin does not have the authority to revoke degrees, a Texas judge ruled yesterday in a case involving a chemist whom the university alleges committed misconduct.

UT revoked Suvi Orr’s PhD in 2014, two years after the retraction of a paper that made up part of her thesis because, according to the retraction notice, some of the study was not reproducible. The university told Orr  — who earned her PhD in 2008 and is now a researcher at Pfizer — that “scientific misconduct occurred in the production of your dissertation,” according to a letter to Orr from Judith Langlois, senior vice provost and dean of graduate studies.

Orr sued UT, which reversed its decision but then tried to again revoke her degree, at which point she sued again, this time also requesting the university cover her legal expenses. Orr alleges in the suit that she was being used as a “sacrificial lamb” to protect her former advisor, who she said made the errors in the paper. Continue reading University of Texas lacks authority to revoke PhDs, judge rules

Is it time for a new research integrity board in the U.S.?

C. K. Gunsalus

Nearly two years ago, a report from the U.S. National Academies of Science, Engineering and Medicine (NASEM) called for a new advisory board that would promote research integrity and tackle misconduct. That board does not yet exist, but today in Nature, five authors, led by C. K. Gunsalus of the University of Illinois at Urbana-Champaign, argue that it should, and describe next steps in its creation. We asked Gunsalus a few questions about the idea.

Retraction Watch (RW): Tell us what the research policy board would do. Who would fund it? Continue reading Is it time for a new research integrity board in the U.S.?